Filing Details

Accession Number:
0001213900-20-006134
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-03-12 16:35:15
Reporting Period:
2020-03-12
Accepted Time:
2020-03-12 16:35:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
811641 Immucell Corp ICCC In Vitro & In Vivo Diagnostic Substances (2835) 010382980
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1529247 David Cunningham C/O Immucell Corporation
56 Evergreen Drive
Portland ME 04103
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.10 Per Share Acquisiton 2020-03-12 2,000 $4.00 15,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct